person

Keith H. Nuechterlein, PhD

Keith Nuechterlein, PhDKeith H Nuechterlein, PhD
as of 2026-07-01
Monitor thisAsk about this
at a glance
Roles: Principal Investigator
Synthesized from structured facts only — each point cited above.

Profile

Affiliation
University of California, Los Angeles
Roles
Principal Investigator
Trial investigator
no

Trials led

5
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
NCT02008773Phase 2Completed
Improving Work Outcome in People With Recent-onset Schizophrenia
NCT00203788Phase 4Completed
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
NCT00333177Phase 4Completed
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
NCT00330551Phase 4Completed
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
NCT05890183—Recruiting

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
PRINCIPAL_INVESTIGATOR
A Double-Blind Trial of Adjunctive Valacyclovir to Improve Cognition in Early Phase Schizophrenia
trial
Improving Work Outcome in People With Recent-onset Schizophrenia
trial
Psychosocial Therapy and Risperidone Treatment in Work Performance in Recent-Onset Schizophrenia
trial
Oral Versus Injectable Risperidone for Treating First-Episode Schizophrenia
trial
Improving Cognition Through Telehealth Aerobic Exercise and Cognitive Training After a First Schizophrenia Episode
trial